Uncategorized | NeoChord

NeoChord Names J. Alex Martin Chairman of the Board

January 2017 CLICK FOR RELEASE

By neochord-admin|2020-11-20T22:12:14+00:00January 23, 2017|Publications, Uncategorized|0 Comments

First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation;

November 2016 click for release

By neochord-admin|2020-11-20T22:12:14+00:00November 10, 2016|Publications, Uncategorized|0 Comments

NeoChord passes 500 patient treatment milestone follow-up data on 127 patients out to two years presented at EACTS;

October 2016 click for release

By neochord-admin|2020-11-20T22:12:14+00:00November 2, 2016|Publications, Uncategorized|0 Comments

NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation;

May 2016 Click for Release

By neochord-admin|2020-11-20T22:12:14+00:00May 13, 2016|Publications, Uncategorized|0 Comments

NeoChord announces appointment of Alex Jonkers as VP of European Commercial Sales and milestone of over 400 patients treated with the DS1000 System;

May 2016 Click for Release

By neochord-admin|2020-11-20T22:12:14+00:00May 5, 2016|Publications, Uncategorized|0 Comments

J. Alex Martin joins NeoChord Board of Directors;

April 2016 Click for Release

By neochord-admin|2020-11-20T22:12:14+00:00April 4, 2016|Publications, Uncategorized|0 Comments

David H. Adams, MD and Michael A. Borger, MD PhD to Serve as National Principal Investigators for NeoChord’s U.S. Pivotal Trial.

March 2016 Click for Release

By neochord-admin|2020-11-20T22:12:15+00:00March 1, 2016|Publications, Uncategorized|0 Comments

NeoChord Again Awarded NUB Status 1 in Germany

February 2016 Click for Release

By neochord-admin|2020-11-20T22:12:15+00:00February 2, 2016|Publications, Uncategorized|0 Comments